Companies including JPMorgan Chase & Co are stepping up to compensate employees ensnared by Hong Kong’s strict quarantine regime, as businesses in the territory struggle to retain and recruit staff almost two years into the COVID-19 pandemic.
As most of the rest of the world is opening up — including rival financial hubs such as Singapore, London and New York — Hong Kong is steadfast in its “COVID-zero” approach, which includes mandating a hotel quarantine of up to three weeks for residents and visitors.
A stay at Hong Kong’s quarantine hotel can cost between HK$500 and HK$3,630 (US$64 and US$465) per night for a non-suite room.
JPMorgan has offered to reimburse Hong Kong employees up to US$5,000 to compensate for their quarantine stay, in a plan that would remain in effect until November next year.
All Hong Kong-based staff members who are executive directors and below could claim the amount for a single quarantine stay for personal trips to visit immediate family members, which includes spouses, domestic partners, children, parents and grandparents.
The US bank has 4,000 employees in the territory.
The New York-based Morgan Stanley has offered employees as much as HK$40,000 to cover quarantine costs. The one-time reimbursement would be available to all Hong Kong permanent employees when they return from a personal trip to visit immediate family members and in effect until November next year.
Goldman Sachs Group Inc has offered employees in the Asia-Pacific region a one-time subsidy of up to US$5,000 to cover costs from a mandatory quarantine effective Dec. 1, a company memo showed.
A Hong Kong-based spokeswoman confirmed the content of the memo.
The subsidy is in recognition that staff members in the Asia-Pacific region have faced the “additional burden of multiple lockdowns and some of the strictest quarantine measures in the world,” the memo said.
Hong Kong needs to achieve a vaccination rate of at least 80 percent before it would consider reopening its borders to mainland China and the international community thereafter, The Standard reported, citing a top government official.
About 70.2 percent of the territory’s population has received at least one COVID-19 vaccine dose, while only 17 percent of older people aged 80 or older have been inoculated, the newspaper quoted Hong Kong Secretary for the Civil Service Patrick Nip (聶德權) as saying in a radio interview on Saturday.
Zhang Yazhou was sitting in the passenger seat of her Tesla Model 3 when she said she heard her father’s panicked voice: The brakes do not work. Approaching a red light, her father swerved around two cars before plowing into a sport utility vehicle and a sedan, and crashing into a large concrete barrier. Stunned, Zhang gazed at the deflating airbag in front of her. She could never have imagined what was to come: Tesla Inc sued her for defamation for complaining publicly about the vehicles brakes — and won. A Chinese court ordered Zhang to pay more than US$23,000 in
‘LEGACY CHIPS’: Chinese companies have dramatically increased mature chip production capacity, but the West’s drive for secure supply chains offers a lifeline for Taiwan When Powerchip Technology Corp (力晶科技) entered a deal with the eastern Chinese city of Hefei in 2015 to set up a new chip foundry, it hoped the move would help provide better access to the promising Chinese market. However, nine years later, that Chinese foundry, Nexchip Semiconductor Corp (合晶集成), has become one of its biggest rivals in the legacy chip space, leveraging steep discounts after Beijing’s localization call forced Powerchip to give up the once-lucrative business making integrated circuits for Chinese flat panels. Nexchip is among Chinese foundries quickly winning market share in the crucial US$56.3 billion industry of so-called legacy
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday held its first board of directors meeting in the US, at which it did not unveil any new US investments despite mounting tariff threats from US President Donald Trump. Trump has threatened to impose 100 percent tariffs on Taiwan-made chips, prompting market speculation that TSMC might consider boosting its chip capacity in the US or ramping up production of advanced chips such as those using a 2-nanometer technology process at its Arizona fabs ahead of schedule. Speculation also swirled that the chipmaker might consider building its own advanced packaging capacity in the US as part
‘NO DISRUPTION’: A US trade association said that it was ready to work with the US administration to streamline the program’s requirements and achieve shared goals The White House is seeking to renegotiate US CHIPS and Science Act awards and has signaled delays to some upcoming semiconductor disbursements, two sources familiar with the matter told reporters. The people, along with a third source, said that the new US administration is reviewing the projects awarded under the 2022 law, meant to boost US domestic semiconductor output with US$39 billion in subsidies. Washington plans to renegotiate some of the deals after assessing and changing current requirements, the sources said. The extent of the possible changes and how they would affect agreements already finalized was not immediately clear. It was not known